Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.

Sugawara A, Kawai K, Motohashi S, Saito K, Kodama S, Yachi Y, Hirasawa R, Shimano H, Yamazaki K, Sone H.

Diabetologia. 2012 Aug;55(8):2128-31. doi: 10.1007/s00125-012-2572-7. Epub 2012 May 12. Erratum in: Diabetologia. 2013 Nov;56(11):2548.

PMID:
22580991
2.

HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.

Hsu CC, Chang HY, Huang MC, Hwang SJ, Yang YC, Lee YS, Shin SJ, Tai TY.

Diabetologia. 2012 Dec;55(12):3163-72. doi: 10.1007/s00125-012-2700-4. Epub 2012 Aug 26.

PMID:
22923064
3.

Intrapersonal HbA(1c) variability and the risk of progression of nephropathy in patients with Type 2 diabetes.

Rodríguez-Segade S, Rodríguez J, García López JM, Casanueva FF, Camiña F.

Diabet Med. 2012 Dec;29(12):1562-6. doi: 10.1111/j.1464-5491.2012.03767.x.

PMID:
22913483
4.

The rise and fall of HbA(1c) as a risk marker for diabetes complications.

Kilpatrick ES.

Diabetologia. 2012 Aug;55(8):2089-91. doi: 10.1007/s00125-012-2610-5. Epub 2012 Jun 19.

PMID:
22711013
5.

Relation of microalbuminuria to glycosylated hemoglobin and duration of type 2 diabetes.

Kundu D, Roy A, Mandal T, Bandyopadhyay U, Ghosh E, Ray D.

Niger J Clin Pract. 2013 Apr-Jun;16(2):216-20. doi: 10.4103/1119-3077.110159.

6.

Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus.

Resl M, Clodi M, Neuhold S, Kromoser H, Riedl M, Vila G, Prager R, Pacher R, Strunk G, Luger A, Hülsmann M.

Diabet Med. 2012 Jun;29(6):721-5. doi: 10.1111/j.1464-5491.2011.03515.x.

PMID:
22050532
7.

Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.

Skriver MV, Støvring H, Kristensen JK, Charles M, Sandbæk A.

Diabetologia. 2012 Sep;55(9):2361-70. doi: 10.1007/s00125-012-2614-1. Epub 2012 Jun 27.

PMID:
22736395
8.

Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients.

Piarulli F, Sartore G, Ceriello A, Ragazzi E, Reitano R, Nollino L, Cosma C, Fedele D, Lapolla A.

Diabetologia. 2009 Jul;52(7):1419-25. doi: 10.1007/s00125-009-1367-y. Epub 2009 Apr 29.

PMID:
19401824
9.

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

Freedman BI, Andries L, Shihabi ZK, Rocco MV, Byers JR, Cardona CY, Pickard MA, Henderson DL, Sadler MV, Courchene LM, Jordan JR, Balderston SS, Graham AD, Mauck VL, Russell GB, Bleyer AJ.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1635-43. doi: 10.2215/CJN.11491210. Epub 2011 May 19.

10.

Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.

Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK.

Diabetes Care. 2000 Oct;23(10):1478-85.

11.

The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.

Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbjörnsdottir S.

Diabetologia. 2012 Nov;55(11):2946-53. doi: 10.1007/s00125-012-2681-3. Epub 2012 Aug 16.

PMID:
22895807
12.

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.

PMID:
17331857
13.

Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.

Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjörnsdottir S; Steering Committee of the Swedish National Diabetes Register.

Diabetes Res Clin Pract. 2005 Mar;67(3):258-66.

PMID:
15713359
14.

Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.

Xu L, Chan WM, Hui YF, Lam TH.

Diabet Med. 2012 Mar;29(3):393-8. doi: 10.1111/j.1464-5491.2011.03456.x.

PMID:
21916977
15.
16.

A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.

Rius Riu F, Salinas Vert I, Lucas Martín A, Romero González R, Sanmartí Sala A.

J Diabetes Complications. 2003 Sep-Oct;17(5):235-42.

PMID:
12954150
17.

Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).

Heianza Y, Arase Y, Hsieh SD, Saito K, Tsuji H, Kodama S, Tanaka S, Ohashi Y, Shimano H, Yamada N, Hara S, Sone H.

Diabetologia. 2012 Dec;55(12):3213-23. doi: 10.1007/s00125-012-2712-0. Epub 2012 Sep 7.

PMID:
22955996
18.

Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.

Ramachandran A, Snehalatha C, Samith Shetty A, Nanditha A.

Diabet Med. 2012 Jan;29(1):94-8. doi: 10.1111/j.1464-5491.2011.03392.x.

PMID:
21790773
19.

Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes.

Kohler KA, McClellan WM, Ziemer DC, Kleinbaum DG, Boring JR.

Am J Kidney Dis. 2000 Nov;36(5):903-13.

PMID:
11054346

Supplemental Content

Support Center